Clinical trial
Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy
NCT02382094 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy
- Lead sponsor
- Karolinska University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- July 31, 2012
- Enrollment
- 110 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer